Sharon K. Gershon

5.4k total citations · 1 hit paper
9 papers, 3.9k citations indexed

About

Sharon K. Gershon is a scholar working on Epidemiology, Infectious Diseases and Geriatrics and Gerontology. According to data from OpenAlex, Sharon K. Gershon has authored 9 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Geriatrics and Gerontology. Recurrent topics in Sharon K. Gershon's work include Global Health Workforce Issues (2 papers), Medical Education and Admissions (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). Sharon K. Gershon is often cited by papers focused on Global Health Workforce Issues (2 papers), Medical Education and Admissions (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). Sharon K. Gershon collaborates with scholars based in United States. Sharon K. Gershon's co-authors include M. Miles Braun, Jeffrey Siegel, Robert P. Wise, William D. Schwieterman, Joseph Keane, John Kasznica, Evelyne T. Edwards, S Brown, Mark H. Greene and Jong‐Hoon Lee and has published in prestigious journals such as New England Journal of Medicine, Psychopathology and Currents in Pharmacy Teaching and Learning.

In The Last Decade

Sharon K. Gershon

9 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2001 2.7k citations Joseph Keane, Sharon K. Gershon et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Sharon K. Gershon

Since Specialization

Citations

This map shows the geographic impact of Sharon K. Gershon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon K. Gershon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon K. Gershon more than expected).

Fields of papers citing papers by Sharon K. Gershon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon K. Gershon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon K. Gershon. The network helps show where Sharon K. Gershon may publish in the future.

Co-authorship network of co-authors of Sharon K. Gershon

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon K. Gershon. A scholar is included among the top collaborators of Sharon K. Gershon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon K. Gershon. Sharon K. Gershon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Public health matters: the role of the pharmacist and the academy 2010 ·Currents in Pharmacy Teaching and Learning ·Ruth E. Nemire, Ceressa T. Ward, Karen Whalen, John Quinn, (unknown), Sharon K. Gershon, (unknown)	8
2	Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents 2003 ·Arthritis & Rheumatism ·Nancy R. Slifman, Sharon K. Gershon, Jong‐Hoon Lee, Evelyne T. Edwards, M. Miles Braun	283
3	Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept 2002 ·Arthritis & Rheumatism ·Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon, Evelyne T. Edwards, William D. Schwieterman, Jeffrey Siegel, Robert P. Wise, S Brown, John N. Udall, M. Miles Braun	337
4	Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration 2002 ·Arthritis & Rheumatism ·S Brown, Mark H. Greene, Sharon K. Gershon, Evelyne T. Edwards, M. Miles Braun	488
5	Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent breakdown → 2001 ·New England Journal of Medicine ·Joseph Keane, Sharon K. Gershon, Robert P. Wise, (unknown), John Kasznica, William D. Schwieterman, Jeffrey Siegel, M. Miles Braun	2706
6	How Many Pharmacists Are in Our Future? The Bureau of Health Professions Projects Supply to 2020 2000 ·Journal of the American Pharmaceutical Association (1996) ·Sharon K. Gershon, James M. Cultice, Katherine K. Knapp	20
7	How Many Pharmacists Are In Our Future?: The Bureau of Health Professions Projects Supply to 2020 2000 ·Journal of Managed Care Pharmacy ·Sharon K. Gershon, James M. Cultice, Katherine K. Knapp	7
8	Sleep and Depression 1987 ·Psychopathology ·(unknown), Sharon K. Gershon, N. Sitaram, M.S. Keshavan	15
9	Treatment-resistant depression in an elderly patient with pancreatic carcinoma: case report. 1984 ·PubMed ·Nunzio Pomara, Sharon K. Gershon	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact